Shanxi Zhendong Pharmaceutical (300158) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.055x

Based on the latest financial reports, Shanxi Zhendong Pharmaceutical (300158) has a cash flow conversion efficiency ratio of -0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-197.94 Million ≈ $-28.96 Million USD) by net assets (CN¥3.63 Billion ≈ $530.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shanxi Zhendong Pharmaceutical - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Shanxi Zhendong Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300158 liabilities breakdown for a breakdown of total debt and financial obligations.

Shanxi Zhendong Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanxi Zhendong Pharmaceutical ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dan Hotels TA:DANH	0.024x
Zhejiang Shengyang Science SHG:603703	0.010x
STEVANATO GROUP SPA O.N. F:87N	0.063x
Prima Andalan Mandiri Tbk PT JK:MCOL	0.113x
DNA Link Inc KQ:127120	-0.030x
Shinry Technologies Co Ltd Class A SHE:300745	0.147x
Total Gabon F:RZW	0.043x
Jiangsu Yawei Machine Tool Co Ltd SHE:002559	0.058x

Annual Cash Flow Conversion Efficiency for Shanxi Zhendong Pharmaceutical (2007–2024)

The table below shows the annual cash flow conversion efficiency of Shanxi Zhendong Pharmaceutical from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 300158 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.66 Billion ≈ $535.61 Million	CN¥-149.82 Million ≈ $-21.92 Million	-0.041x	-10.85%
2023-12-31	CN¥5.14 Billion ≈ $752.74 Million	CN¥-189.95 Million ≈ $-27.80 Million	-0.037x	-323.47%
2022-12-31	CN¥5.22 Billion ≈ $764.33 Million	CN¥86.31 Million ≈ $12.63 Million	0.017x	-53.21%
2021-12-31	CN¥8.05 Billion ≈ $1.18 Billion	CN¥284.45 Million ≈ $41.62 Million	0.035x	-10.36%
2020-12-31	CN¥5.63 Billion ≈ $824.31 Million	CN¥221.94 Million ≈ $32.48 Million	0.039x	+15.04%
2019-12-31	CN¥5.44 Billion ≈ $796.21 Million	CN¥186.35 Million ≈ $27.27 Million	0.034x	+18.89%
2018-12-31	CN¥5.36 Billion ≈ $784.69 Million	CN¥154.48 Million ≈ $22.60 Million	0.029x	+255.11%
2017-12-31	CN¥5.56 Billion ≈ $813.28 Million	CN¥45.09 Million ≈ $6.60 Million	0.008x	+195.63%
2016-12-31	CN¥5.27 Billion ≈ $771.41 Million	CN¥-44.72 Million ≈ $-6.54 Million	-0.008x	-111.34%
2015-12-31	CN¥2.03 Billion ≈ $297.12 Million	CN¥151.84 Million ≈ $22.22 Million	0.075x	+101.19%
2014-12-31	CN¥1.97 Billion ≈ $288.29 Million	CN¥73.23 Million ≈ $10.72 Million	0.037x	+197.00%
2013-12-31	CN¥1.96 Billion ≈ $286.56 Million	CN¥-75.04 Million ≈ $-10.98 Million	-0.038x	-138.43%
2012-12-31	CN¥1.90 Billion ≈ $277.96 Million	CN¥189.40 Million ≈ $27.72 Million	0.100x	+308.83%
2011-12-31	CN¥1.86 Billion ≈ $271.95 Million	CN¥-88.73 Million ≈ $-12.98 Million	-0.048x	-362.53%
2010-12-31	CN¥1.78 Billion ≈ $260.67 Million	CN¥32.40 Million ≈ $4.74 Million	0.018x	-84.54%
2009-12-31	CN¥359.31 Million ≈ $52.58 Million	CN¥42.28 Million ≈ $6.19 Million	0.118x	-5.43%
2008-12-31	CN¥266.72 Million ≈ $39.03 Million	CN¥33.18 Million ≈ $4.86 Million	0.124x	-82.94%
2007-12-31	CN¥176.42 Million ≈ $25.82 Million	CN¥128.65 Million ≈ $18.82 Million	0.729x	--

About Shanxi Zhendong Pharmaceutical

SHE:300158 China Drug Manufacturers - Specialty & Generic

Market Cap

$830.57 Million

CN¥5.68 Billion CNY

Market Cap Rank

#9965 Global

#2831 in China

Share Price

CN¥5.72

Change (1 day)

-0.35%

52-Week Range

CN¥3.88 - CN¥9.45

All Time High

CN¥12.00